Your browser doesn't support javascript.
loading
3D Functional Genomics Screens Identify CREBBP as a Targetable Driver in Aggressive Triple-Negative Breast Cancer.
Peck, Barrie; Bland, Philip; Mavrommati, Ioanna; Muirhead, Gareth; Cottom, Hannah; Wai, Patty T; Maguire, Sarah L; Barker, Holly E; Morrison, Eamonn; Kriplani, Divya; Yu, Lu; Gibson, Amy; Falgari, Giulia; Brennan, Keith; Farnie, Gillian; Buus, Richard; Marlow, Rebecca; Novo, Daniela; Knight, Eleanor; Guppy, Naomi; Kolarevic, Daniela; Susnjar, Snezana; Milijic, Natasa Medic; Naidoo, Kalnisha; Gazinska, Patrycja; Roxanis, Ioannis; Pancholi, Sunil; Martin, Lesley-Ann; Holgersen, Erle M; Cheang, Maggie C U; Noor, Farzana; Postel-Vinay, Sophie; Quinn, Gerard; McDade, Simon; Krasny, Lukas; Huang, Paul; Daley, Frances; Wallberg, Fredrik; Choudhary, Jyoti S; Haider, Syed; Tutt, Andrew N; Natrajan, Rachael.
Afiliación
  • Peck B; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Bland P; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Mavrommati I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Muirhead G; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Cottom H; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Wai PT; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Maguire SL; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Barker HE; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Morrison E; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Kriplani D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Yu L; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Gibson A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Falgari G; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, Northern Ireland, United Kingdom.
  • Brennan K; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Farnie G; Division of Stem Cells and Cancer, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia.
  • Buus R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Marlow R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Novo D; Division of Cancer Biology, The Institute of Cancer Research, London, England, United Kingdom.
  • Knight E; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Guppy N; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Kolarevic D; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Susnjar S; Division of Molecular Pathology, The Institute of Cancer Research, London, England, United Kingdom.
  • Milijic NM; Faculty of Life Sciences, University of Manchester, Manchester, England, United Kingdom.
  • Naidoo K; SGC Oxford, University of Oxford, Oxford, England, United Kingdom.
  • Gazinska P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Pancholi S; Breast Cancer Now Research Unit, King's College London, London, England, United Kingdom.
  • Martin LA; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Holgersen EM; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Cheang MCU; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Noor F; The Royal Marsden NHS Foundation Trust, London, England, United Kingdom.
  • Postel-Vinay S; Department of Medical Oncology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
  • Quinn G; Department of Pathology and Cytology, The Institute of Oncology and Radiology of Serbia, Belgrade, Serbia.
  • McDade S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Krasny L; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Huang P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Daley F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Wallberg F; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Choudhary JS; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Haider S; Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, England, United Kingdom.
  • Tutt AN; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, England, United Kingdom.
  • Natrajan R; Department of Drug Development (DITEP), Gustave Roussy Cancer Campus, Université Paris-Saclay, Villejuif, France.
Cancer Res ; 81(4): 847-859, 2021 02 15.
Article en En | MEDLINE | ID: mdl-33509944
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de Unión a CREB / Neoplasias de la Mama Triple Negativas / Carcinogénesis Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteína de Unión a CREB / Neoplasias de la Mama Triple Negativas / Carcinogénesis Límite: Animals / Female / Humans Idioma: En Revista: Cancer Res Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido